Mylan's Acquisition of Matrix |
ICMR HOME | Case Studies Collection
For delivery in electronic format: Rs. 400; For delivery through courier (within India): Rs. 400 + Shipping & Handling Charges extra
» Business Strategy Case Studies
Custom Search
Please note: |
||||||||
"This is an extremely complementary transaction that accomplishes a number of Mylan's key objectives. Mylan is executing on its commitment to establish a global platform and expand its dosage forms and therapeutic categories. Additionally, this acquisition deepens Mylan's vertical integration and enhances its supply chain capabilities. The transaction will allow Mylan and Matrix to strengthen and expand their core businesses and competencies, while creating significant opportunities for global expansion and growth."1 - Robert J Coury, Vice Chairman and CEO, Mylan Inc. in 2006. "A player has to decide how he can stay in the field for as long as possible. Matrix, as a significant API supplier, needed a bigger playing field. Partnering with Mylan gives us that."2 , 3 - Nimagadda Prasad, Executive Chairman, Matrix Laboratories Ltd. in 2006. "Clearly, we're seeing a trend in the industry toward acquisitions and consolidation... This is a continuing trend to move more sourcing and manufacturing overseas and to own it as opposed to just contracting it."4 - Martha Freitag, an industry analyst at Argus Research Corp.5, in 2006. Benefits Beyond Global Expansion
expand beyond our well-established position as a leading domestic generic pharmaceutical company toward our objective of establishing Mylan as a world leader in generics and specialty pharmaceuticals."8 Mylan's Acquisition of Matrix - Next Page>>
Custom Search
1] "Mylan Laboratories to Acquire Up to 71.5%
Controlling Interest in Matrix Laboratories,"www.matrixlabsindia.com,
August 28, 2006.
|
Case Studies Links:-
Case Studies,
Short Case Studies,
Simplified Case Studies. |